期刊文献+

2型糖尿病患者血清超灵敏C反应蛋白水平的检测 被引量:7

Determination of serum highly sensitive C-reactive protein in patients with type 2 diabetes
暂未订购
导出
摘要 目的 探讨2型糖尿病患者血清超灵敏C反应蛋白(hs-CRP)水平与机体胰岛素敏感性的关系。方法 运用高灵敏酶联免疫吸附法检测68例2型糖尿病患者和20名健康对照者的血清hs-CRP水平,同时检测血糖、血清胰岛素、糖基化血红蛋白(HbAlc)、尿白蛋白排泌率和血脂,并计算稳态模型胰岛素抵抗指数(HOMA-IR指数)和胰岛B细胞分泌指数(HOMA-IS)以分别反映机体的胰岛素敏感性和胰岛素分泌功能。结果2型糖尿病患者的血清hs-CRP水平显著高于对照(P<0.01),HOMA-IR指数和HOM-IS指数均低于正常对照(P<0.01)。进一步将患者按HbAlc分为血糖控制良好组(n=42)和血糖控制欠佳组(n=23)后发现,控制欠佳组的血清hs-CRP水平显著高于控制良好组(P<0.05)。线性相关分析显示,糖尿病患者的血清hs-CRP水平均与HbAlc、空腹血糖、体质量指数、舒张压和HOMA-IS指数呈显著正相关。结论 2型糖尿病患者血清hs-CRP水平高于正常人,而且与糖尿病的发生、发展有密切的关系。 Objective To investigate the relationship between serum level of highly sensitive C-reactive protein (hs-CRP) and insulin sensitivity in type 2 diabetic patients. Methods Serum hs-CRP level was determined by highly sensitive enzyme-linked immunosorbent assay (ELISA) in 65 patients with type 2 diabetes and 25 normal controls. Plasma glucose, serum insulin, glycosylated hemoglobin (HbA1c), urinary albumin excretion rate (UAER), plasma lipids and lipoprotein were also measured. Moreover, homeostasis model analysis (HOMA) of insulin resistance index (HOMA-IR) and islet secretion index (HOMA-IS) were calculated to estimate the insulin sensitivity and islet function. Results In the patients with type 2 diabetes, serum hs-CRP was increased, HOMA-IR index and HOMA-IS index were decreased as compared with the normal control subjects (P<0.01). Moreover, serum hs-CRP was significantly higher in poorly controlled diabetic patients (n=23) with HbA1c≥7% than that in well controlled diabetic patients (n=42) with HbA1c<7%. Liner regression analysis in diabetic patients showed that serum hs-CRP was negatively correlated with HOMA-IS index but positively correlated with fasting plasma glucose, body mass index, HbA1c and diastolic blood pressure, respectively. Conclusion Serum HS-CRP level is higher in the patients with type 2 diabetes than in normal subjects, and plays an role in the development and progression of type 2 diabetes mellitus.
出处 《第一军医大学学报》 CSCD 北大核心 2004年第7期791-793,共3页 Journal of First Military Medical University
基金 广东省卫生厅基金(A2000378)~~
关键词 C反应蛋白/血液 2型糖尿病/诊断 胰岛素敏感性 C-reactive protein/blood diabetes,type 2/diagnosis insulin sensitivity
  • 相关文献

参考文献9

  • 1Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study [ J ]. Diabetes, 2001, 50 (10):2384-9.
  • 2Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein. interleukin 6, and risk of developing type 2 diabetes mellitus [J ]. JAMA,2001, 18, 286(3): 327-34.
  • 3Forouhi NG, Satter N, McKeigue PM. Relation of C-reactive protein to body distribution and feature of the metabolic syndrome in Europeans and South Asians[J]. Int J Obes Relat Metab Disord, 2001, 25(9): 1327-31.
  • 4Moro E, Gallina P, Pais G, et al. Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with 1999World Health Organization criteria for the classification of diabetes[J]. Metabolism, 2003, 52(5): 616-9.
  • 5Haffner SM, Mykkanen L, Festa A, et al. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects[J ]. Circulation, 2000, 101: 975-80.
  • 6Kelly CC, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome [J]. J Clin Endocrinol Metab, 2001, 86(6): 2453-5.
  • 7Pannacciuilli N, Cantatore FP, Minenna A, et al. C-reactive protein is independent associated with total body fat, center fat, and insulin resistance in adult women[J]. Int J Obes Relat Metab Disord, 2001, 25(10): 1416-20.
  • 8Festa A, D'Agostino R, Howard G, et al. Chronic sub-clinical inflammation as part of the insulin-resistance syndrome: the insulin resistance atherosclerosis study (IRAS)[J ]. Circulation, 2000,102(1): 42-7.
  • 9Rodriguez-Moran M; Guerrero-Romero F. Increased levels of C-reactive protein in non-controlled type Ⅱ diabetic subjects [J]. J Diabetes Complications, 1999, 13(4): 211-5.

同被引文献38

  • 1吴恒莲,林宏初,陈月影,刘国辉,张秀薇,阮雪玲,区冰玲,郑东文,彭伟成,黄娇平,张丽梅.氟伐他汀治疗早期糖尿病肾病疗效分析[J].中国实用内科杂志,2004,24(8):486-487. 被引量:18
  • 2侯卫红,赵变香,黄佩荣,关卿.怡开治疗糖尿病肾病68例疗效观察[J].临床医药实践,2007,16(1):41-42. 被引量:3
  • 3Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease : prospective study and updated meta-analysis [J]. BMJ, 2000, 321, 199-204.
  • 4Koenig W. Predicting risk and treatment benefit in atherosclerosis: the role of C- reactive protein [J]. Int J Cardiol, 2005, 98 (2): 199 - 206.
  • 5Aso Y, Yoshida N, Okumura K, et al. Result of blood inflammatory markers areassociated more strongly with toe-brachial index than with ankle-brachial index in patients with type 2 diabetes [J]. Diabetes Care, 2004, 27 (6): 1381-1386.
  • 6Spranger J, Kroke A, Mohlig M, et al. Inflmtory cytokines and the risk to develop type 2 diabetes: results of the prospective population based European Prospective Investigation into Cancer and Nutrition (EPIC) -Potsdam Study [J]. Diabetes, 2003, 52 (3): 812-817.
  • 7Barzilay J I, Abraham L, Heckbert S R, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study [J]. Diabetes, 2001, 50 (10): 2384 - 2389.
  • 8Freeman D J, Norrie J, Caslake M J, et al. C- reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study [J]. Diabetes, 2002, 51 : 1596-1600.
  • 9[1]Spranger J,Kroke A,Mohlig M,et al.Inflammatory cytokines and the risk to devdlop type 2 diabetes:results of the prospective populationbased European Prospective Investigation into Cancer and Nutrition(EPIC)-Potsdam Study.Diabetes,2003,52(3):812-817
  • 10[2]Pradhan AD,Manson JE,Rifai N,et al.C-reactive protein,interleukin 6,and risk of developing type2 diabetes mellitus.JAMA,2001,286(3):327-334

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部